raistthemage: True perhaps, Pride and arrogance often times destroys good relationships. Although I've never met John Thero personally, I believe he's a good man with good values. He means well by the shareholders.
As for his character, I base my assumptions on who he has hired, I met Elizabeth Schwartz a year ago January when I met her along with JMCRR. At that time Amarin was gearing up for the ADCOM to come in October 2019. I felt Amarin was in good hands and JT was a man I could trust. I still feel that way.
Kennedy I don't know either so I can't judge anyone. I just know (gut feel) that Amarin will come through this alright. Most likely not how we had all dreamed it would but nonetheless a viable product that sells itself. Although it doesn't have the brand recognition yet.... The process by which Vascepa is produced is key.
The generics will do all they can to cheapen the product, try and undercut Amarin's pricing, but they won't have Amarin's Process capabilities when it comes to Quality and Safety. I ask; how many times has anyone been given a generic that didn't work as well as a brand name? It happens a large percentage of the time.
GLTA "we've yet begun to fight" John Paul Jones. On this sad occasion too, September 11, 2020....
Nukle head
News 
Market Data 
Discover 
